JAMES B BREITMEYER Insider Trading $OTIC OTONOMY, INC.

FREE EMAIL WATCHDOG

Get free email notifications about insider trading for JAMES B BREITMEYER.

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insider Transactions | Monthly Overview

Get the latest insider transactions of JAMES B BREITMEYER. JAMES B BREITMEYER is VP PHARMACEUTICAL OPERATIONS in CytoCore, Inc. ($AMEV) and Chief Executive Officer in Oncternal Therapeutics, Inc. ($GTXI) and President, CEO in GTX INC /DE/ ($GTXI) and Director in ZOGENIX, INC. ($ZGNX) and Director in OTONOMY, INC. ($OTIC).

JAMES B BREITMEYER in OTONOMY, INC.

Trading Symbol: OTIC
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of JAMES B BREITMEYER: Director
Holdings: 0 shares
Current Value: $0
Latest Transaction: Jun 25 2020
$OTIC Market Capitalization: $442.34M
$OTIC Previous Close: $14.50

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD

Latest Insider Trading Transactions of JAMES B BREITMEYER in OTONOMY, INC.

1 Week2 Weeks1 Month3 Months6 Months1 Year2 Years
No. of Purchases0000000
Value of Purchases ($)0000000
No. of Sales0000000
Value of Sales ($)0000000

Sentiment: All, AMEV, ONCT, OTIC, ZGNX

Page:   1

DateTickerCompanyOwnerRelationship Transaction Code Cost ($) Shares Transaction Value ($) Total Shares % Holdings
Jun 25 2020OTICOTONOMY, INC.BREITMEYER JAMES BDirectorOption ExerciseA3.5617,50062,30017,500
Jun 13 2019OTICOTONOMY, INC.BREITMEYER JAMES BDirectorOption ExerciseA2.3517,50041,12517,500
Jun 20 2018OTICOTONOMY, INC.BREITMEYER JAMES BDirectorOption ExerciseA4.4535,000155,75035,000

Page:   1